Brenntag SE

XTRA:BNR Lagerbericht

Marktkapitalisierung: €7.8b

Brenntag Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Brenntag wird ein jährliches Gewinn- und Umsatzwachstum von 23.4% bzw. 2.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 23.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.7% betragen.

Wichtige Informationen

23.4%

Wachstumsrate der Gewinne

23.62%

EPS-Wachstumsrate

Trade Distributors Gewinnwachstum13.2%
Wachstumsrate der Einnahmen2.7%
Zukünftige Eigenkapitalrendite12.73%
Analystenabdeckung

Good

Zuletzt aktualisiert16 Jun 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Analyseartikel • Aug 15

Earnings Miss: Brenntag SE Missed EPS By 64% And Analysts Are Revising Their Forecasts

XTRA:BNR 1 Year Share Price vs Fair Value Explore Brenntag's Fair Values from the Community and select yours Brenntag...

Recent updates

Narrativ-Update • Jun 06

BNR: Resilient Demand Expectations Will Still Leave Execution Risks In Focus

The analyst fair value estimate for Brenntag has increased from €42.00 to €44.00, reflecting higher price targets from analysts, including recent upgrades that cite more resilient second half demand and a smaller expected price roll off compared with peers. Analyst Commentary Recent research on Brenntag shows a mix of optimism and caution.
Narrativ-Update • May 23

BNR: Resilient Demand And Higher Discount Rate Will Shape Fairly Balanced Outlook

The analyst price target for Brenntag has shifted from roughly €53.86 to about €56.43. Analysts cite more resilient second half demand, a smaller price roll off versus peers, and recent rating and target increases from several firms as key drivers of the change.
Narrativ-Update • May 01

BNR: Higher Discount Rate And Lower P E May Cap Share Price

Analysts have trimmed their Brenntag price target slightly from about €54.50 to roughly €53.86. This reflects updates to assumptions on discount rate, revenue growth, profit margin and future P/E following recent UBS and Deutsche Bank research.
Narrativ-Update • Apr 15

BNR: Dividend And Epoxy Expansion Are Expected To Support Re Rating

Analysts have nudged their price target for Brenntag slightly higher to about €68, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple following recent research, including an upgrade at a major bank. Analyst Commentary Recent research points to a more constructive tone around Brenntag, with bullish analysts aligning their models to the updated assumptions on revenue growth, profit margins and future P/E multiples that underpin the new price target around €68.
Narrativ-Update • Apr 01

BNR: Sector Headwinds And Execution Risks Will Sustain Earnings Pressure

Narrative Update The analyst price target for Brenntag has been adjusted to €50. Analysts cite updated 2026 sector views, a more cautious stance on chemical distribution and staffing peers, and revised assumptions for discount rate, revenue growth, profit margin, and future P/E.
Narrativ-Update • Mar 18

BNR: Distribution Execution And Staffing Risks Will Sustain Earnings Pressure

Analysts have reduced their Brenntag price target to €50 from €63, citing a more cautious stance on chemical distribution and staffing within the broader European business services group. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Brenntag, pointing to risks around execution in chemical distribution and staffing within the broader European business services group.
Narrativ-Update • Mar 04

BNR: Expanded Epoxy Partnership Will Support A More Constructive Long Term View

Our Brenntag narrative has been updated to reflect a lower analyst price target of €50, down from €63, as analysts factor in more cautious assumptions on revenue growth, profit margins and sector conditions, even while using a slightly higher discount rate and a higher future P/E multiple. Analyst Commentary The latest rating and price target move to €50 comes as part of a broader 2026 reassessment of European business services and chemical distribution names.
Narrativ-Update • Feb 18

BNR: Chemical Distribution Concerns Will Sustain Earnings Pressure And Extended Multiple Compression

Analysts have cut their price target on Brenntag to €50 from €63, reflecting a more cautious view on chemical distribution as they update their 2026 outlook and favor other business services names instead. Analyst Commentary Bearish analysts have moved Brenntag to a less favorable rating and cut the price target to €50 from €63, signaling a stricter view on what they are willing to pay for the shares in the medium term.
Narrativ-Update • Feb 03

BNR: Chemical Distribution Execution Risk Will Pressure Earnings And Sustain Multiple Compression

Narrative update on Brenntag Analysts have trimmed their average price target for Brenntag to €50 from €63. This reflects a more cautious view on chemical distribution and related business services, while still keeping fair value assumptions broadly unchanged.
Narrativ-Update • Jan 20

BNR: Staffing And Chemical Distribution Risks Will Pressure Earnings And Sustain Multiple Compression

Narrative Update on Brenntag Brenntag's analyst price target has been cut to €50 from €63, with analysts citing a more cautious view on chemical distribution and staffing exposure within their 2026 outlook. Analyst Commentary Bearish analysts have shifted their stance on Brenntag, cutting the price target to €50 from €63 and moving the rating to Underweight.
Narrativ-Update • Jan 06

BNR: Weaker Chemical Demand Will Pressure Earnings And Sustain Multiple Compression

Analysts have trimmed their average price targets on Brenntag to a range around €45 to €50, reflecting more cautious views on chemical distribution volumes and the company's growth profile. Analyst Commentary Recent research updates on Brenntag point to a more cautious stance on the stock, with several bearish analysts rethinking both ratings and price targets in light of concerns around chemical distribution and the company's growth profile.
Analyseartikel • Dec 31

Is There An Opportunity With Brenntag SE's (ETR:BNR) 49% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Brenntag fair value estimate is €96.93 Current share price of...
Narrativ-Update • Dec 18

BNR: Weaker Chemical Demand Will Pressure Earnings And Drive Multiple Compression

Analysts have reduced their price target on Brenntag from about EUR 47 to EUR 42. This reflects expectations for a weaker growth profile and a deteriorating chemical market backdrop, even as margins hold up and valuation multiples compress slightly.
Narrativ-Update • Dec 04

BNR: Share Price Will Rebound As Cost Efficiencies Support Earnings Resilience

The analyst price target for Brenntag has been trimmed slightly from EUR 54.67 to about EUR 54.50, as analysts factor in a weaker chemical market backdrop, lower expected growth, and modestly softer profitability assumptions. Analyst Commentary Recent Street research reflects a more cautious stance on Brenntag, with several firms lowering price targets and reassessing the companys risk reward profile in light of a softer chemical demand outlook.
Analyseartikel • Nov 29

Here's Why Brenntag (ETR:BNR) Can Manage Its Debt Responsibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Narrativ-Update • Nov 20

BNR: Share Price Will Rebound As Chemical Market Challenges Ease

Brenntag's analyst fair value estimate has declined from €57.24 to €54.67, as analysts cite a weaker growth outlook and challenging chemical market conditions as reasons for the reduced price target. Analyst Commentary Recent analyst updates on Brenntag reflect a shift in sentiment as experts weigh the company’s outlook in the context of ongoing market challenges and valuation considerations.
Analyseartikel • Nov 09

Brenntag SE's (ETR:BNR) Shares May Have Run Too Fast Too Soon

It's not a stretch to say that Brenntag SE's ( ETR:BNR ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...
Narrativ-Update • Nov 05

BNR: Share Price Will Reflect Sector Headwinds as Market Conditions Stabilize

Brenntag's consensus analyst price target has been lowered noticeably in recent updates. Analysts cite a challenging chemical market environment and expectations for slower growth as key factors behind the revised outlook.
Narrativ-Update • Oct 22

Analyst Commentary Signals Lower Growth Expectations as Brenntag Faces Reduced Price Targets

Brenntag's analyst price target has been revised downward by approximately EUR 3 to EUR 57, as analysts point to ongoing reductions in expected growth and profitability in light of a challenging market backdrop. Analyst Commentary Recent analyst coverage of Brenntag reflects a cautious sentiment across the market, with lowered price targets and revised outlooks highlighting ongoing concerns about the company's growth prospects and market challenges.
Narrativ-Update • Oct 08

Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value

Brenntag's analyst price target has been reduced by several euros, as analysts cite lower expectations for revenue growth, profit margins, and sector cyclicality. Analyst Commentary Recent street research updates reflect a mixed outlook on Brenntag, with several analysts adjusting their ratings and lowering price targets in light of the company’s ongoing performance and sector trends.
Analyseartikel • Sep 20

Return Trends At Brenntag (ETR:BNR) Aren't Appealing

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Narrativ-Update • Sep 05

Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value

Analysts have maintained a cautious outlook on Brenntag due to its increased earnings cyclicality, macroeconomic uncertainties, and negative FX impacts, resulting in an unchanged consensus price target at €62.83. Analyst Commentary Bearish analysts cite increased cyclicality in Brenntag’s business versus specialty distributors, leading to greater earnings volatility.
Analyseartikel • Aug 15

Earnings Miss: Brenntag SE Missed EPS By 64% And Analysts Are Revising Their Forecasts

XTRA:BNR 1 Year Share Price vs Fair Value Explore Brenntag's Fair Values from the Community and select yours Brenntag...
Analyseartikel • Jul 17

We Think Brenntag (ETR:BNR) Can Stay On Top Of Its Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel • Jun 28

Brenntag SE's (ETR:BNR) Prospects Need A Boost To Lift Shares

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") above 20x, you may consider...
User avatar
Neues Narrativ • Nov 25

Decisive Acquisitions And Digital Innovations Propel Transformation Amid Challenges

Strategic focus on divisional optimization and cost containment is set to enhance revenue and improve net margins by reducing expenses.

Gewinn- und Umsatzwachstumsprognosen

XTRA:BNR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202816,09163561495712
12/31/202715,57456459792713
12/31/202615,28450547478013
3/31/202614,762228657948N/A
12/31/202515,172265674967N/A
9/30/202515,649419670989N/A
6/30/202516,000424585908N/A
3/31/202516,307530569901N/A
12/31/202416,237536564907N/A
9/30/202416,1915456721,054N/A
6/30/202416,2106038211,188N/A
3/31/202416,2916401,0781,421N/A
12/31/202316,8157151,3431,664N/A
9/30/202317,6076821,2861,565N/A
6/30/202318,6197531,2791,551N/A
3/31/202319,4238531,0551,322N/A
12/31/202219,429887690957N/A
9/30/202218,737843421659N/A
6/30/202217,374754221442N/A
3/31/202215,783600135346N/A
12/31/202114,383448189389N/A
9/30/202113,221501435613N/A
6/30/202112,364461684864N/A
3/31/202111,7164509041,092N/A
12/31/202011,7954671,0201,219N/A
9/30/202012,0454659651,174N/A
6/30/202012,4194757861,009N/A
3/31/202012,851476704922N/A
12/31/201912,822467N/A879N/A
9/30/201912,829483N/A787N/A
6/30/201912,796467N/A621N/A
3/31/201912,757460N/A549N/A
12/31/201812,550461N/A375N/A
9/30/201812,288394N/A340N/A
6/30/201811,959383N/A341N/A
3/31/201811,745372N/A317N/A
12/31/201711,743361N/A405N/A
9/30/201711,502401N/A394N/A
6/30/201711,229394N/A450N/A
3/31/201710,892389N/A517N/A
12/31/201610,498360N/A540N/A
9/30/201610,337334N/A654N/A
6/30/201610,325335N/A641N/A
3/31/201610,352340N/A633N/A
12/31/201510,346365N/A594N/A
9/30/201510,384393N/A501N/A
6/30/201510,364386N/A441N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BNRDas prognostizierte Gewinnwachstum (23.4% pro Jahr) liegt über der Sparquote (1.9%).

Ertrag vs. Markt: BNRDie Erträge des Unternehmens (23.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (17.1% pro Jahr).

Hohe Wachstumserträge: BNREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: BNRDie Einnahmen des Unternehmens (2.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (6.7% pro Jahr).

Hohe Wachstumseinnahmen: BNRDie Einnahmen des Unternehmens (2.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BNRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.7%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/06/22 00:16
Aktienkurs zum Tagesende2026/06/22 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Brenntag SE wird von 29 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Volker BosseBaader Helvea Equity Research
Gaurav JainBarclays
James StewartBarclays